Senior Editor, Diagnostic Imaging
Iodinated Contrast Media Alternative: FDA OKs Bayer Importing Foreign-Labeled Iopromide
July 19th 2022The Food and Drug Administration (FDA) has given the green light to Bayer to import foreign-labeled iopromide (Ultravist) to help alleviate ongoing supply challenges with iodinated contrast media in the United States.
Radialis Garners FDA 510(k) Clearance for Portable PET Device
July 19th 2022Offering images of high spatial resolution and a small system footprint, the new positron emission tomography (PET) modality from Radialis may facilitate enhanced imaging of emerging radiotracer agents and key biomarkers in targeted organs.
Key MRI Patterns for Diagnosing Inflammatory Brain Stem Lesions
July 16th 2022In an award-winning presentation at the European Congress of Radiology (ECR), researchers from the Hospital Universitario Basurto in Spain reviewed key neuroimaging findings on magnetic resonance imaging (MRI) for a variety of inflammatory lesions of the brain stem.
New Study Says Five Out of Eight Face Masks Are 'MRI Unsafe'
July 11th 2022In their testing of eight commercially available filtering face piece (FFP3) respirators commonly utilized during the COVID-19 pandemic, researchers deemed that five of the face masks that contained ferromagnetic materials were unsafe to use in and around magnetic resonance imaging (MRI) devices.
Study Confirms Higher Accuracy of MRI Over Emerging PSMA PET/CT for Diagnosing Prostate Cancer
July 8th 2022Magnetic resonance imaging (MRI) had better accuracy than prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) “for detecting any grade of prostate cancer,” according to new study findings presented at the European Association of Urology Annual Congress (EAU22) in Amsterdam.
CMS Declines to Expand Coverage of Computed Tomography Colonography (CTC) for Medicare Beneficiaries
July 7th 2022Citing “insufficient” evidence, the Centers for Medicare and Medicaid Services (CMS) has declined a formal request by the American College of Radiology and multiple patient advocacy groups to reevaluate the lack of Medicare and Medicaid coverage of computed tomography colonography (CTC) for colorectal cancer screening.
Eight Perspectives from Radiology Organizations on the Overturning of Roe v. Wade
July 2nd 2022In recently issued statements, different radiology organizations have offered perspectives on the physician-patient relationship and the potential impact of the Supreme Court’s decision to overturn Roe v. Wade.
MRI Study Reveals Increased Brain Changes in Postmenopausal Women
July 1st 2022Emerging research with brain magnetic resonance imaging (MRI) scans shows that postmenopausal women have higher amounts of white matter hyperintensities that may lead to elevated risks for cognitive dysfunction and stroke.
Philips Adds Proteomic Nodule Risk Assessment to Lung Cancer Orchestrator System
June 30th 2022The addition of Biodesix’s Nodify Lung nodule risk assessment tool to Philips’ lung cancer patient management system may enhance diagnostic efficiency and facilitate improved management of high-risk patients.
Colorectal Cancer Screening: Could a Lower Age Threshold Reveal Greater Screening Disparities?
June 30th 2022In a large study looking at the use of colorectal cancer screening techniques (including computed tomography (CT) colonography) between 2000 and 2018, researchers found that the 50 to 54 age group had the lowest increases in screening and a significantly higher chasm of racial and socioeconomic disparities in comparison to other age groups.
New Study Shows Link Between COVID-19 and Elevated Risks for Neurological Disorders
June 25th 2022Emerging research showed that patients with COVID-19 had 3.5 times the risk for developing Alzheimer’s disease and 2.6 times the risk for Parkinson’s disease in comparison to those who did not have COVID-19.
Could an MRI-Based Machine Learning Model Facilitate Enhanced Detection of Alzheimer's Disease?
June 22nd 2022New research suggests that an emerging predictive biomarker, derived from a combination of magnetic resonance imaging (MRI) brain scans and a machine learning algorithm, has significantly greater accuracy than previously established measurements for diagnosing Alzheimer’s disease.
Essential Questions for Assessing Artificial Intelligence Vendors in Radiology
June 21st 2022In a recent video interview, abdominal radiologist Sonia Gupta, MD discussed key principles in assessing potential alliances with artificial intelligence (AI) vendors and the potential of AI to alleviate the time-consuming, administrative aspects of patient care.
Study Finds Key Benefits and Low Use of Pre-Op MRI for Patients Having Surgery for Prostate Cancer
June 17th 2022Despite increased use of preoperative magnetic resonance imaging (MRI) in recent years for patients undergoing surgery for prostate cancer, a study found that over 70 percent of a large Medicare population with prostate cancer did not have a preoperative MRI scan as of 2015.
AI Software Facilitates 22.1 Percent Reduction in Chest CT Review Time
June 17th 2022Noting that an AI software platform could save radiologists up to an hour a day in interpreting chest computed tomography (CT) scans, the authors of a prospective study found shorter mean interpretation times with non-contrast and contrast-enhanced CT as well as positive CT scans with and without significant new findings.
Is Whole Body Imaging Warranted for Thrombocytopenia Caused by a COVID-19 Vaccine?
June 14th 2022In what may be the largest study to date to examine the use of whole-body imaging to assess multisystem thrombosis in patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, researchers found multiple sites of thrombosis in 83 percent of patients who had additional CT, MRI and/or ultrasound imaging beyond the area of their primary complaint.